1Y Annualised Return
▼-40.79%
3Y Annualised Return
▼-18.05%
5Y Annualised Return
▼-4.73%
Ortin Laboratories Stock Performance
|
|
|
Ortin Laboratories Company background
Founded in: 1986
Managing director: S Murali Krishna Murthy
Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations.The company offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anticold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers. They also produce dental, ophthalmology, pediatric, diuretics, dermatology, psychiatry, and ENT drugs. The company constructed a Factory in a spacious area of 25,000 sq feet with all ultramodern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders ointments. During the year 200304, the company started their second division of products and marketing in few states. During the year 200607, the company got listed their shares in BSE Indonext model, which provided a nationwide trading platform for the investors of the company for their effective participation. They completed the up gradation of factory premises as per Revised Schedule M and started exporting their products to Asian, African countries and Middle East countries.During the year 200910, the company acquired the certification for the registration with National Drug Authority, Uganda wherein the company has got the eligibility to export their products to Uganda.During the year 201011, Vineet Laboratories Pvt Ltd, a private limited company engaged in the manufacturing of Fine Chemicals, Custom synthesis and specialized in making bulk drug intermediates for anti retrovirals and lipid lowering agents, etc was amalgamated with the company. Also, the company was allotted 6.18 acres of land in IDA, Buchinelli, Zaheerabad, Medak Dist., AP by APIIC. The company is planning to construct USFDA and European Standard Bulk Drug manufacturing facility.In 201011, M/s. Vineet Laboratories Private Limited (VLPL) was merged with the Company through the Scheme of Amalgamation, which was made effective from October 01, 2010. In terms of the said Scheme of Amalgamation, the Equity Shareholders of VLPL were entitled 17 Equity Shares of the Company for every 10 Equity Share held in Vineet Laboratories Private Limited. Thus, 1,22,40,000 fully paidup equity shares of Rs. 10/ each of the Company were issued and allotted to the equity shareholders of Vineet Laboratories Private Limited in the same proportion as to their shareholding in Vineet Laboratories Private Limited.In 201718, the scheme of arrangement between the Company and Vineet Laboratories Limited for demerger of the API Intermediates Division of the Company as a going concern was implemented.
As of 10 Jul, 2025, Ortin Laboratories share price is ₹11.7. The stock opened at ₹11.6 and had closed at ₹11.8 the previous day. During today’s trading session, Ortin Laboratories share price moved between ₹11.90 and ₹11.90, with an average price for the day of ₹11.90. Over the last 52 weeks, the stock has recorded a low of ₹9.57 and a high of ₹24.96. In terms of performance, Ortin Laboratories share price has declined by 33.3% over the past six months and has declined by 40.79% over the last year.
Ortin Laboratories SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹53,32,609 (-17.96%)
Daily SIP of ₹25,000 would have become ₹53,32,609 in 1 year with a gain of ₹-11,67,390 (-17.96%)
Ortin Laboratories Fundamental
Market Cap (in crs)
9.68
Face Value
10
Turnover (in lacs)
0.02
Key Metrics
Qtr Change %
52.86% Fall from 52W High
6.8
Dividend yield 1yr %
0
Ortin Laboratories Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Ortin Laboratories Quarterly Revenue
| Jun 2012 | Mar 2012 | Jun 2011 |
|---|---|---|
15.93 Cr | 19.75 Cr | 19.81 Cr |
Ortin Laboratories Yearly Revenue
| Mar 2012 |
|---|
85.86 Cr |
Ortin Laboratories Quarterly Net Profit/Loss
| Jun 2012 | Mar 2012 | Jun 2011 |
|---|---|---|
0.44 Cr | 1.42 Cr | 1.2 Cr |
Ortin Laboratories Yearly Net Profit/Loss
| Mar 2012 |
|---|
4.62 Cr |
Ortin Laboratories Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
11.9
Current Price
5Day EMA
11.70
10Day EMA
11.70
12Day EMA
11.70
20Day EMA
11.70
26Day EMA
11.60
50Day EMA
11.60
100Day EMA
12.40
200Day EMA
14.20
5Day SMA
11.70
10Day SMA
11.80
20Day SMA
11.70
30Day SMA
11.50
50Day SMA
11.40
100Day SMA
11.50
150Day SMA
13.50
200Day SMA
15.00
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 1589 Rs | 1589 Rs |
Week Rs | 3769 Rs | 3769 Rs |
Month Rs | 9070 Rs | 9070 Rs |
Resistance & Support
11.61
Pivot
Resistance
First Resistance
11.84
Second Resistance
11.98
Third Resistance
12.21
Support
First Support
11.47
Second support
11.24
Third Support
11.10
Relative Strength Index
51.49
Money Flow Index
42.67
MACD
0.08
MACD Signal
0.12
Average True Range
0.65
Average Directional Index
11.41
Rate of Change (21)
5.69
Rate of Change (125)
-34.16
Ortin Laboratories Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.10 | 8.40 | 1.9 | 5.27 | 2.12 | -1.41% | -17.32% | -40.17% | -58.42% | -89.23% | 0.00% | 0.00 | 42.76 | 2.09 | |
39.41 | 18.01 | 37.87 | 88.7 | 38.64 | -5.88% | -33.10% | -34.26% | -49.51% | 40.75% | 0.00% | 36.16 | 42.76 | 1.56 | |
Kobo Biotech Ltd. | 2.77 | 2.77 | - | - | - | - | - | - | - | - | - | - | - | - |
9.25 | 9.48 | 6.7 | 13.47 | 8.81 | 3.24% | -0.64% | -2.63% | 11.71% | 131.25% | 0.00% | 92.50 | 42.76 | 10.53 | |
- | 9.86 | 9.4 | 26.01 | 17.19 | -7.67% | 2.62% | -20.29% | 12.26% | 92.57% | 0.00% | 0.00 | 42.76 | -6.60 | |
3.99 | 9.97 | 2.97 | 24.5 | 4.07 | -5.67% | -1.48% | 19.82% | -83.01% | -83.24% | 0.00% | 0.00 | 42.76 | 0.24 |
Ortin Laboratories Share Price FAQs
What is Share Price of Ortin Laboratories ?
Ortin Laboratories share price is ₹11.9 in NSE and ₹11.9 in BSE as on 10/7/2025.
How has Ortin Laboratories shares performed in the past ?
Ortin Laboratories share price in the past 1-year return was -39.59. The Ortin Laboratories share hit a 1-year low of Rs. 9.57 and a 1-year high of Rs. 24.96.
What is the market cap of Ortin Laboratories ?
The market cap of Ortin Laboratories is Rs. 9.68 Cr. as of 10/7/2025.
What is the current P/E ratio of Ortin Laboratories ?
The PE ratios of Ortin Laboratories is 0 as of 10/7/2025.
What is the current PB ratio of Ortin Laboratories ?
The PB ratios of Ortin Laboratories is 4.88 as of 10/7/2025
How to buy Ortin Laboratories shares?
You can easily buy Ortin Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Ortin Laboratories ?
The 52-week high and low of Ortin Laboratories share price is ₹24.96 and ₹9.57 as of 10/7/2025.
Please be aware that Ortin Laboratories stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account